A Study of Veliparib in Combination With Carboplatin and Paclitaxel in Japanese Subjects With Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1
Clinical Trials Related to Solid Tumors
Related studies linked through entity extraction aliases.
A Dose Escalation Study of OMP-54F28 in Subjects With Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1
A Phase 1 Dose Escalation Study of AV-203, an ERBB3 Inhibitory Antibody, in Subjects With Advanced Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1
A Study of LY2875358 in Japanese Participants With Advanced Cancer
- Status
- COMPLETED
- Phase
- PHASE1
Treatment Extension Study for Patients Who Have Previously Participated and Have Benefited From Iniparib in a Clinical Trial
- Status
- COMPLETED
- Phase
- PHASE3
PU-H71 in Patients With Solid Tumors and Low-Grade Non-Hodgkin's Lymphoma That Have Not Responded to Standard Treatment
- Status
- TERMINATED
- Phase
- PHASE1
A Phase 1 Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of MEDI0639 in Advanced Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1
Nivestim® (Filgrastim) Tolerance in Patients Treated by Toxic Chemotherapeutic Agents
- Status
- COMPLETED
- Phase
- N/A
A Trial of Gefitinib in Combination With BKM120 in Patients With Advanced Non-Small Cell Lung Cancer, With Enrichment for Patients Whose Tumours Harbour Molecular Alterations of PI3K Pathway and Known to Overexpress EGFR
- Status
- COMPLETED
- Phase
- PHASE1
Imetelstat for Children With Refractory or Recurrent Solid Tumors and Lymphoma
- Status
- WITHDRAWN
- Phase
- PHASE1
Phase 1 Study of ONT-10 in Patients With Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1
Dose-Finding Study of Cabozantinib (XL184) in Japanese Subjects With Advanced Cancer
- Status
- COMPLETED
- Phase
- PHASE1
Determination of Dose of Antiangiogenic Multitargeted DOVITINIB (TKI258) Plus Paclitaxel in Patients With Solid Tumors
- Status
- TERMINATED
- Phase
- PHASE1
Dose Escalation Study of the Safety and Pharmacokinetics of ME-344 Single Agent for Refractory Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1
Safety of 24-Hour Infusion of ON 01910.Na in Patients With Advanced Cancer
- Status
- COMPLETED
- Phase
- PHASE1
Safety of ON 01910.Na as a 3-day Infusion in Patients With Advanced Cancer
- Status
- COMPLETED
- Phase
- PHASE1
A Trial of Oral 5-azacitidine in Combination With Romidepsin in Advanced Solid Tumors, With an Expansion Cohort in Virally Mediated Cancers and Liposarcoma
- Status
- COMPLETED
- Phase
- PHASE1
Erlotinib in Combination With Pralatrexate in Advanced Malignancies
- Status
- COMPLETED
- Phase
- PHASE1
Metformin in Children With Relapsed or Refractory Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1
Safety Study of PLX3397 and Paclitaxel in Patients With Advanced Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1